1. 2772 Circulating tumor cells kinetics in ovarian carcinoma: correlation with baseline characteristics and CA-125 levels in the randomized ANTHALYA trial evaluating bevacizumab in the neoadjuvant setting. (September 2015) Authors: Cottu, P.; Rouge, T. De La Motte; Pautier, P.; Provansal, M.; Floquet, A.; Selle, F.; Mouret-Reynier, M.A.; Fabbro, M.; Kalbacher, E.; Piprot, C.; Follana, P.; Lesoin, A.; Medioni, J.; Menguy, V.; Ghazi, Y.; Bidard, F.C.; Dubot, C.; Joly, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial. Issue 2 (1st May 2015) Authors: Helissey, C.; Berger, F.; Cottu, P.; Diéras, V.; Mignot, L.; Servois, V.; Bouleuc, C.; Asselain, B.; Pelissier, S.; Vaucher, I.; Pierga, J.Y.; Bidard, F.C. Journal: Cancer letters Issue: Volume 360:Issue 2(2015) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0159: Disseminated tumor cells as factor of benefit of regional lymph nodes irradiation in breast cancer. (April 2018) Authors: Mignot, F.; Bidard, F.C.; Dureau, S.; Fourquet, A.; Berger, F.; Loirat, D.; Proudhon, C.; Vincent-Salomon, A.; Pierga, J.Y.; Kirova, Y. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SP-0572: Circulating tumour DNA, a new tool for the early detection of poor outcome. (May 2017) Authors: Bidard, F.C. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗